Amphoteric Mannan as an Immune Response Modifier. New Model Immunobiologically ActiveCandida albicansMannan-Based Formula

Authors:

Abstract
Currently, the incidence and prevalence of serious fungal infections is increasing, especially in immunosuppressed individuals. The co-administration of antibiotic and immunosuppressive therapies h...
Funding Information
  • Grant Agency of the Slovak Academy of Sciences VEGA (2/0076/21)
  • lovak Research and Development Agency (APVV-15-0161)
  • Operational Program Integrated Infrastructure for the project Study of structural changes of complex glycoconjugates in the process of inherited metabolic and civilization diseases, ITMS (313021Y920)
  • European Regional Development Fund and is based upon work from COST Action CA16231 ENOVA
  • CEMBAM – Centre for Medical Bio-Additive Manufacturing and Research (ITMS2014+: 313011V358)

This publication has 71 references indexed in Scilit: